Preoperative assessment of these prognostic biomarkers might help in planning treatment strategies to improve patient outcomes, according to an article published in Journal of Pancreatic Cancer, a peer-reviewed open access publication from Mary Ann Liebert, Inc., publishers. The article is available on the Journal of Pancreatic Cancer website. Read more . . .
A new study of patients who underwent curative surgical removal of a pancreatic ductal adenocarcinoma showed that two of the nine preoperative factors analyzed were strongly predictive of poor prognosis regardless of the tumor stage.